Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy

Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody

(2019) Xiao Han et al.   JOURNAL OF CONTROLLED RELEASE

Valor terapéutico potencial de las estrategias dirigidas contra la interleucina 1β en la enfermedad cardiovascular ateroesclerótica

(2019) Vanesa Viana-Huete et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Red Blood Cells as Smart Delivery Systems

(2018) Xiao Han et al.   BIOCONJUGATE CHEMISTRY

Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club

(2018) Francesco Burzotta et al.   EuroIntervention

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

(2018) Marnix Lameijer et al.   Nature Biomedical Engineering

Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice

(2018) Yanan Song et al.   Nanomedicine-Nanotechnology Biology and Medicine

Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis

(2018) Kathryn J. Moore et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Platelet for drug delivery

(2018) Yifei Lu et al.   CURRENT OPINION IN BIOTECHNOLOGY

PEDF improves atherosclerotic plaque stability by inhibiting macrophage inflammation response

(2017) Hao Wen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

NLRP3 inflammasome: Its regulation and involvement in atherosclerosis

(2017) Zahra Hoseini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis

(2017) Andrey Lozhkin et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mechanisms of foam cell formation in atherosclerosis

(2017) Dimitry A. Chistiakov et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol

(2017) Patrick R. Lawler et al.   Journal of the American Heart Association

In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy

(2017) Chao Wang et al.   Nature Biomedical Engineering

Non-HDL Cholesterol and TriglyceridesHighlights

(2016) Rishi Puri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inflammatory cytokines in atherosclerosis: current therapeutic approaches

(2016) Dimitris Tousoulis et al.   EUROPEAN HEART JOURNAL

Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013

(2015) Gregory A. Roth et al.   CIRCULATION

Inflammation and plaque vulnerability

(2015) G. K. Hansson et al.   JOURNAL OF INTERNAL MEDICINE

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

(2015) Rebecca C Coll et al.   NATURE MEDICINE

Anti-inflammatory therapies for atherosclerosis

(2015) Magnus Bäck et al.   Nature Reviews Cardiology

Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality

(2015) Gregory A. Roth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Platelets in Inflammation and Atherogenesis

(2015) Henry M. Nording et al.   Frontiers in Immunology

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation

(2015) J. Tang et al.   Science Advances